These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39226803)
1. Up-regulated DSG2 promotes tumor growth and reduces immune infiltration in cervical cancer. Zhang G; Chen Z; Wang Y; Huang A; Nie F; Gao L; Wang Y; Ren F Pathol Res Pract; 2024 Oct; 262():155554. PubMed ID: 39226803 [TBL] [Abstract][Full Text] [Related]
2. Significance of desmoglein-2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer. Zhou BX; Li Y Kaohsiung J Med Sci; 2020 May; 36(5):336-343. PubMed ID: 31930774 [TBL] [Abstract][Full Text] [Related]
3. DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer. Qin S; Liao Y; Du Q; Wang W; Huang J; Liu P; Shang C; Liu T; Xia M; Yao S Cancer Cell Int; 2020; 20():206. PubMed ID: 32514251 [TBL] [Abstract][Full Text] [Related]
4. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer. Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of desmoglein 2 promotes EMT progression in gallbladder cancer. Wang L; Lv Y; Li J; Nan Y; Piao L; Liang Z Histol Histopathol; 2023 Apr; 38(4):467-474. PubMed ID: 36259602 [TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-related gene transferrin receptor protein 1 expression correlates with the prognosis and tumor immune microenvironment in cervical cancer. Shang X; Wang H; Gu J; Zhao X; Zhang J; Sun B; Zhu X PeerJ; 2024; 12():e17842. PubMed ID: 39131609 [TBL] [Abstract][Full Text] [Related]
7. Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing. Zhao F; Hong J; Zhou G; Huang T; Lin Z; Zhang Y; Liang L; Tang H Front Immunol; 2024; 15():1434450. PubMed ID: 39224598 [TBL] [Abstract][Full Text] [Related]
8. Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients. Han CP; Yu YH; Wang AG; Tian Y; Zhang HT; Zheng ZM; Liu YS Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5481-5489. PubMed ID: 30229819 [TBL] [Abstract][Full Text] [Related]
9. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2. Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878 [TBL] [Abstract][Full Text] [Related]
10. DSG2 expression is low in colon cancer and correlates with poor survival. Yang T; Gu X; Jia L; Guo J; Tang Q; Zhu J; Zhao W; Feng Z BMC Gastroenterol; 2021 Jan; 21(1):7. PubMed ID: 33407183 [TBL] [Abstract][Full Text] [Related]
11. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer. Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172 [TBL] [Abstract][Full Text] [Related]
12. SQLE-a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration. Zhao YC; Li YF; Qiu L; Jin SZ; Shen YN; Zhang CH; Cui J; Wang TJ BMC Cancer; 2024 Sep; 24(1):1133. PubMed ID: 39261819 [TBL] [Abstract][Full Text] [Related]
13. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway. Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer. Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737 [TBL] [Abstract][Full Text] [Related]
15. LINC01089 inhibits the progression of cervical cancer via inhibiting miR-27a-3p and increasing BTG2. Li S; Han Y; Liang X; Zhao M J Gene Med; 2021 Jan; 23(1):e3280. PubMed ID: 33025678 [TBL] [Abstract][Full Text] [Related]
16. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells. Hütz K; Zeiler J; Sachs L; Ormanns S; Spindler V Mol Carcinog; 2017 Aug; 56(8):1884-1895. PubMed ID: 28277619 [TBL] [Abstract][Full Text] [Related]
17. FOXP3‑induced LINC00885 promotes the proliferation and invasion of cervical cancer cells. Liu Y; Tu H; Zhang L; Xiong J; Li L Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880574 [TBL] [Abstract][Full Text] [Related]
18. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells. Huang Y; Luo F IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1. Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129 [TBL] [Abstract][Full Text] [Related]
20. Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer. Chang PH; Chen MC; Tsai YP; Tan GYT; Hsu PH; Jeng YM; Tsai YF; Yang MH; Hwang-Verslues WW Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]